MIRAI

MIRAI is a Tokyo-based venture capital firm specializing in early-stage investments in the healthcare and technology sectors. The firm focuses on identifying and supporting innovative startups that have the potential to transform these industries. By providing strategic guidance and capital, MIRAI aims to foster the growth of companies that are developing cutting-edge solutions to address complex challenges in healthcare and technology.

In November 2022, MIRAI led a Series A financing round totaling ¥100 million for a Japanese nuclear medicine startup. This investment underscores the firm's commitment to advancing medical technologies and supporting ventures that contribute to the improvement of healthcare services. MIRAI's strategic approach involves thorough due diligence and a collaborative partnership with portfolio companies to ensure mutual success.

With a dedicated team of professionals, MIRAI leverages its extensive network and industry expertise to offer comprehensive support to its investees. The firm's proactive involvement in the growth and development of its portfolio companies reflects its long-term investment philosophy and dedication to fostering innovation in Japan's healthcare and technology sectors.